APOL1 and focal segmental glomerulosclerosis: This gain-of-function mutation in APOL1 triggers podocyte toxicity through endoplasmic reticulum stress, autophagy, and disruptions in ion flow, leading to the development of associated nephropathies such as FSGS [9,16–18].